Skip to main content Accesibility Help
×
×
Home

IMPROVING THE EFFECTIVENESS AND EFFICIENCY OF EVIDENCE PRODUCTION FOR HEALTH TECHNOLOGY ASSESSMENT

  • Karen Facey (a1), Chris Henshall (a2), Laura Sampietro-Colom (a3) and Sarah Thomas (a4)
Abstract

Objectives: Health Technology Assessment (HTA) needs to address the challenges posed by high cost, effective technologies, expedited regulatory approaches, and the opportunities provided by collaborative real-world evaluation of technologies. The Health Technology Assessment International (HTAi) Policy Forum met to consider these issues and the implications for evidence production to inform HTA. This paper shares their discussion to stimulate further debate.

Methods: A background paper, presentations, group discussions, and stakeholder role play at the 2015 HTAi Policy Forum meeting informed this paper.

Results: HTA has an important role to play in helping improve evidence production and ensuring that the health service is ready to adopt effective technologies. It needs to move from simply informing health system decisions to also working actively to align stakeholder expectations about realistic evidence requirements. Processes to support dialogue over the health technology life cycle need to be developed that are mindful of limited resources, operate across jurisdictions and learn from past processes. Collaborations between health technology developers and health systems in different countries should be encouraged to develop evidence that will inform decision making. New analytical techniques emerging for real-world data should be harnessed to support modeling for HTA.

Conclusions: A paradigm shift (to “Health Innovation System 2.0”) is suggested where HTA adopts a more central, proactive role to support alignment within and amongst stakeholders over the whole life cycle of the technology. This could help ensure that evidence production is better aligned with patient and health system needs and so is more effective and efficient.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      IMPROVING THE EFFECTIVENESS AND EFFICIENCY OF EVIDENCE PRODUCTION FOR HEALTH TECHNOLOGY ASSESSMENT
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      IMPROVING THE EFFECTIVENESS AND EFFICIENCY OF EVIDENCE PRODUCTION FOR HEALTH TECHNOLOGY ASSESSMENT
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      IMPROVING THE EFFECTIVENESS AND EFFICIENCY OF EVIDENCE PRODUCTION FOR HEALTH TECHNOLOGY ASSESSMENT
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
Hide All
1. HTAi. About HTAi policy forum. http://www.htai.org/policy-forum/about-htai-policy-forum.html (accessed March 10, 2015).
2. Facey, K. Background paper—Improving the effectiveness and efficiency of evidence production for HTA, in the light of current trends in drug and device development, health system funding, regulation and HTA. HTAi: Alberta; 2015. http://www.htai.org/policy-forum/about-htai-policy-forum.html (accessed May 8, 2015).
3. Thirteen New York Public Media. About the Fred Friendly Seminars. http://www.thirteen.org/bid/p-friendly.html (accessed March 10, 2015).
4. Chalmers, I, Glasziou, P. Avoidable waste in the production and report of research evidence. Lancet. 2009;374:8689.
5. National Institute for Health Research. What is adding value in research? http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0005/80159/NIHR-Adding-Value-in-Research-A5-Flyer_Sept2013.pdf (accessed May 6, 2015).
6. Schneeweiss, S, Shrank, WH, Ruhl, M, Maclure, MK. Decision-making aligned with rapid-cycle evaluation in health care. Int. J. Health Care Technol. Assess. 2015;31: 214222.
7. Levin, L. Early evaluation of new health technologies: The case for premarket studies that harmonize regulatory and coverage perspectives. Int. J. Health Care Technol. Assess. 2015;31: 207209.
8. Montilla, S, Xoxi, E, Russo, P, Cicchetti, A, Pani, L. Monitoring registries at Italian Medicines Agency: Fostering access, guaranteeing sustainability. Int. J. Health Care Technol. Assess. 2015;31: 210213.
9. European Medicines Agency. Adaptive pathways. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000601.jsp (accessed March 18, 2015).
10. FDA. Guidance for industry expedited programs for serious conditions—Drugs and biologics. Washington, DC: FDA; 2014.
11. Garau, M, Towse, A, Garrison, L, Housman, L, Ossa, D. Can and should value based pricing be applied to molecular diagnostics? London: Office of Health Economics; 2012.
12. Parvizi, N, Woods, K. Regulation of medicines and medical devices: Contrasts and similarities. Clin Med. 2014;14:612.
13. KNAW. Evaluation of new technology in healthcare. In need of guidance for relevant evidence. Amsterdam: KNAW; 2014. https://www.knaw.nl/nl/actueel/publicaties/evaluation-of-new-technology-in-health-care/@@download/pdf_file/verkenning-new-technology-health-care.pdf (accessed December 31, 2014).
14. Dillon, A. Responsiveness, language, and alignment: Reflections on some challenges for health technology assessment. Int. J. Health Care Technol. Assess. 2015;31: 223225.
15. NICE. Scientific advice. https://www.nice.org.uk/about/what-we-do/scientific-advice (accessed March 30, 2015).
16. CADTH scientific advice. Welcome to the CADTH Scientific Advice website. http://scientificadvice.cadth.ca/ (accessed March 30, 2015).
17. SEED. Shaping European early dialogues. http://www.earlydialogues.eu/has/ (accessed May 6, 2015).
18. Killalea, S, Osipenko, L, Pavlovic, M, Grueger, J. Early scientific advice from regulators and HTA. Themed Edition in Values and Outcomes Spotlight. 2015;1:513.
19. EUnetHTA. JA2 WP7 - Methodology development and evidence generation: Guidelines and pilots production. www.eunethta.eu/activities/EUnetHTA%20Joint%20Action%202%20%282012--15%29/ja2-wp7-methodology-development-and-evidence-generation (accessed May 8, 2015).
20. Green Park Collaborative USA. Working together to improve the quality of reimbursement science – 2015 progress report. USA: CMTP; 2015.
21. van Staa, TP, Dyson, L, McCann, G, et al. The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials. Health Technol Assess. 2014;18:1146.
22. NOPR. Welcome to the National Oncologic PET registry. https://www.cancerpetregistry.org/ (accessed March 21, 2015).
23. Kaiser Permanente Institute for Health Policy. Tracking surgical outcomes: Kaiser Permanente's Total Joint Replacement Registry. 2012. Kaiser Foundation Health Plan, Inc. http://www.kpihp.org/wp-content/uploads/2012/09/KPStories-v1-no6-TJRR-FINAL.pdf (accessed March 27, 2015).
24. FDA. FDA's Sentinel initiative. http://www.fda.gov/Safety/FDAsSentinelInitiative/ucm2007250.htm (accessed March 27, 2015).
25. Schneeweiss, S. Learning from big health care data. N Engl J Med. 2014;370:21612163. doi:10.1056/NEJMp140111.
26. Get Real. Welcome to the Get Real website. http://www.imi-getreal.eu/ (accessed September 23, 2014).
27. Bergvall-Kåreborn, B, Ihlström Eriksson, C, Ståhlbröst, A, et al. A milieu for innovation—Defining living labs. Presented at the 2nd ISPIM Innovation Symposium, New York, December 6–9, 2009. https://pure.ltu.se/portal/files/3517934/19706123_Paper.pdf (accessed December 31, 2014).
28. Koller, C. New hepatitis C—Old problems. Milbank Memorial Fund. http://www.milbank.org/the-view-from-here/new-hepatitis-c-drug-old-problems (accessed May 6, 2015).
29. Sampietro-Colom, L, Thomas, S, Henshall, C. Toward a shifting health technology assessment paradigm: Reactions to policy forum discussions. Int. J. Health Care Technol. Assess. 2015;31: 228229.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Journal of Technology Assessment in Health Care
  • ISSN: 0266-4623
  • EISSN: 1471-6348
  • URL: /core/journals/international-journal-of-technology-assessment-in-health-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Type Description Title
WORD
Supplementary materials

Facey et al. supplementary material
Supllementary table

 Word (23 KB)
23 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed